CD276 and neoplasm: Another important immune-checkpoint gene CD276, also known as B7-H3, has been observed to be up-regulated in the high-risk group, which is consistent with the previous evidence that CD276 is generally overexpressed in tumor tissues compared to normal tissues and could lead to worse survival (Zhou and Jin, 2021).